{ Periapproval }
DaVita Clinical Research (DCR) is your partner for periapproval studies beginning at regulatory filing or when pivotal trials are nearing completion and extending through approval, the launch period, and the remaining development life cycle of a drug. DCR’s periapproval services include Phase IIb-IV studies, risk management plans, registry studies, epidemiology, and pharmacovigilance.
Periapproval strategies have become increasingly important to maximize “product assets” while the products are still covered by patents. Periapproval studies now augment new product launches, where otherwise product exclusivity could be lost with expiration of a patent.
DCR periapproval specialists can address all your post-marketing needs, from well-defined study design to observational studies and monitoring.
